全文获取类型
收费全文 | 19429篇 |
免费 | 1417篇 |
国内免费 | 44篇 |
专业分类
耳鼻咽喉 | 193篇 |
儿科学 | 701篇 |
妇产科学 | 547篇 |
基础医学 | 2667篇 |
口腔科学 | 205篇 |
临床医学 | 2355篇 |
内科学 | 3624篇 |
皮肤病学 | 344篇 |
神经病学 | 2004篇 |
特种医学 | 518篇 |
外国民族医学 | 5篇 |
外科学 | 2156篇 |
综合类 | 151篇 |
一般理论 | 14篇 |
预防医学 | 2342篇 |
眼科学 | 271篇 |
药学 | 1245篇 |
中国医学 | 16篇 |
肿瘤学 | 1532篇 |
出版年
2024年 | 34篇 |
2023年 | 247篇 |
2022年 | 464篇 |
2021年 | 840篇 |
2020年 | 447篇 |
2019年 | 809篇 |
2018年 | 873篇 |
2017年 | 621篇 |
2016年 | 660篇 |
2015年 | 710篇 |
2014年 | 953篇 |
2013年 | 1112篇 |
2012年 | 1711篇 |
2011年 | 1710篇 |
2010年 | 846篇 |
2009年 | 722篇 |
2008年 | 1181篇 |
2007年 | 1184篇 |
2006年 | 1053篇 |
2005年 | 992篇 |
2004年 | 910篇 |
2003年 | 717篇 |
2002年 | 654篇 |
2001年 | 98篇 |
2000年 | 103篇 |
1999年 | 87篇 |
1998年 | 143篇 |
1997年 | 93篇 |
1996年 | 82篇 |
1995年 | 57篇 |
1994年 | 62篇 |
1993年 | 46篇 |
1992年 | 59篇 |
1991年 | 44篇 |
1990年 | 36篇 |
1989年 | 45篇 |
1988年 | 52篇 |
1987年 | 44篇 |
1986年 | 34篇 |
1985年 | 32篇 |
1984年 | 23篇 |
1983年 | 27篇 |
1982年 | 22篇 |
1981年 | 20篇 |
1980年 | 20篇 |
1979年 | 18篇 |
1978年 | 15篇 |
1976年 | 20篇 |
1974年 | 21篇 |
1973年 | 20篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
81.
Ashley D. Marumoto MD Srivarshini C. Mohan MD Stephanie A.K. Angarita MD Marissa K. Srour MD Vicky E. Norton Farnaz Dadmanesh MD Armando E. Giuliano MD 《The breast journal》2021,27(11):828-831
For women with breast cancer in whom multiple Oncotype DX® Recurrence Scores (RS) are obtained, RS concordance utilizing current NCCN recommendations has not been evaluated. Patients with two or more RS were identified. RS were stratified by NCCN guidelines and compared for concordance. Twenty-four patients were evaluated. RS concordance varied by tumor type: 100% in the same tumor, 91.7% in multiple ipsilateral tumors, 71.4% in contralateral tumors, and 66.7% in in-breast recurrent tumors. RS concordance for multiple assays in the same patient is not high enough to omit Oncotype DX® testing for each tumor. 相似文献
82.
Jessica K. Salwen-Deremer Jennifer M. Lauretti Kelly A. Aschbrenner Leslie Heinberg Stephen J. Ritz Stephanie Sogg 《Surgery for obesity and related diseases》2021,17(6):1182-1189
BackgroundA psychosocial evaluation is an important component of the preoperative assessment process for people seeking metabolic and bariatric surgery (MBS), and is required for accreditation of MBS programs. Recently, independent companies without affiliations with MBS programs have been marketing remotely administered, unaffiliated psychosocial evaluations for MBS (RUS), and American Society for Metabolic and Bariatric Surgery (ASMBS) members have raised concerns about these evaluations.ObjectivesTo explore ASMBS members’ beliefs about RUS.SettingOnline survey.MethodsWe developed a survey to evaluate ASMBS members’ opinions, experiences, and/or concerns about in-person and RUS psychosocial evaluations for MBS.ResultsIn total, 635 ASMBS members responded to the online survey and 156 responded to an open-ended question on RUS. Responses were coded based on a manual developed for this study, yielding themes of concerns about the quality of RUS, lack of ongoing relationships in RUS, and conditions under which/reasons why RUS evaluations could be acceptable.ConclusionRespondents expressed both interest in and concerns about RUS in pre-MBS psychosocial evaluations. Use of RUS has the potential to improve access to MBS by providing a convenient and efficient means of completing the psychosocial evaluation. Conversely, respondents expressed concerns about the background and training of RUS providers, the quality of the reports, and the limited relationships between the RUS provider and both the MBS patient and the MBS team. We discuss the clinical and research implications of response themes, particularly for patients in rural areas or those who have other barriers to care. 相似文献
83.
Corinne N. Thompson Scott Hughes Stephanie Ngai Jennifer Baumgartner Jade C. Wang Emily McGibbon Katelynn Devinney Elizabeth Luoma Daniel Bertolino Christina Hwang Kelsey Kepler Cybill Del Castillo Melissa Hopkins Henry Lee Andrea K. DeVito Jennifer L. Rakeman PhD Anne D. Fine 《MMWR. Morbidity and mortality weekly report》2021,70(19):712
84.
Attard Ritienne Dingli Philip Doggen Carine J. M. Cassar Karen Farrugia Rosienne Bezzina Wettinger Stephanie 《Zeitschrift fur Gesundheitswissenschaften》2021,29(3):611-624
Journal of Public Health - To determine the risk of myocardial infarction (MI) associated with pattern, frequency, and intensity of alcohol consumption, type of alcoholic beverage, and the combined... 相似文献
85.
86.
87.
Mark C Gillies Anne Mv Brooks Stephanie Young Bill Gillies Judy M Simpson Ivan Goldberg 《Clinical & experimental ophthalmology》1999,27(1):37-44
Purpose: The aim of the present study was to investigate the safety and potential efficacy of subconjunctival interferon-α2b (IFN-α), either alone or in combination with 5-fluorouracil (5-FU), in reducing the risk of failure of glaucoma surgery. Methods: A prospective, masked randomized phase II study was undertaken in which patients received three subconjunctival injections per week for 3–4 weeks postoperatively. Three treatments were compared: (i) IFN-α (1 × 10 6 IU per dose); (ii) 5-FU (5 mg per dose); and (iii) alternating IFN-α and 5-FU (BOTH). The primary outcome measures were: (i) rate of successful control of intra-ocular pressure without further surgery; and (ii) the incidence of side effects. Results: Fifty-seven patients undergoing glaucoma surgery with an increased risk of failure were evaluated, including 23 patients (40%) undergoing trabeculectomy combined with extracapsular cataract extraction as well as other conventional high-risk groups. With 53 patients (93%) completing 2 years follow up, there was no significant difference in success rates among the three groups. Intra-ocular pressure was controlled without further surgery in 79% of patients (95% confidence interval (CI): 61, 97%) receiving IFN-α, in 89% of patients (76, 100%) receiving 5-FU and in 89% of patients (76, 100%) receiving BOTH. Side effects were similar among the three groups. Conclusions: These results are consistent with a beneficial effect of IFN-α2b given either alone or in combination with 5-FU after glaucoma filtering surgery. However, the lack of a clear and substantial benefit over conventional anti-fibrotic therapy does not support the further clinical evaluation of these treatments. 相似文献
88.
Circulating growth factor levels are associated with tumorigenesis in neurofibromatosis type 1. 总被引:2,自引:0,他引:2
George A Mashour Pablo Hernáiz Driever Melanie Hartmann Stephanie N Drissel Tingguo Zhang Bianca Scharf Ursula Felderhoff-Müser Sadatoshi Sakuma Reinhard E Friedrich Robert L Martuza Victor Felix Mautner Andreas Kurtz 《Clinical cancer research》2004,10(17):5677-5683
PURPOSE: Neurofibromatosis type 1 (NF1) is characterized by systemic development of neurofibromas. Early clinical diagnosis can be ambiguous, and genetic diagnosis can be prohibitively difficult. Dysregulation of a number of growth factors has been suggested to be a mechanism of pathogenesis. This study was performed to assess the contribution of circulating growth factors for diffuse tumorigenesis and the diagnostic value of circulating growth factor identification in serum. EXPERIMENTAL DESIGN: The growth stimulation of neurofibroma-derived cells by serum from NF1 patients was tested, and serum growth factor levels in a cohort of NF1 patients (n = 39) between the ages of 7 and 70 years were analyzed. RESULTS: Concentrations of midkine (MK) and stem cell factor, but not epidermal growth factor, were substantially increased in serum of NF1 patients when compared with healthy controls. Within the NF1 group, MK levels increased dramatically at puberty from an average of 0.79 ng/mL in patients <18 years to 1.18 ng/mL in patients >18 years old. Stem cell factor and MK concentrations above a defined threshold in serum of NF1 patients are of diagnostic benefit for 96% of patients in the cohort tested. Furthermore, serum from NF1 patients enhanced proliferation of human neurofibroma-derived primary Schwann cells and endothelial cells substantially better than normal serum. CONCLUSIONS: Enhanced circulating growth factor levels contribute to diffuse tumorigenesis in NF1 and may provide the basis for molecular diagnosis. 相似文献
89.
90.
Cellulose-based composites have attracted interest given the shift towards ‘green’ materials, but achieving uniform dispersions of cellulose in polymer matrices and/or enhancement of interfacial interactions between components remains challenging. Herein we report the preparation of polypyrrole/cellulose nanocomposites in [Cu(NH3)4(H2O)2](OH)2 (Schweizer''s reagent/cuoxam)-based reaction media via in situ polymerization. The effect of cellulose template morphology and reaction media on the microstructure, electrical conductivity, and surface wettability was studied. Aqueous reaction media favored the formation of a uniform polypyrrole coating encapsulating the cellulose fibers; concentrated cuoxam solutions promoted inhomogeneity and exhibited a progressive decline in conductivity. The maximum conductivity attained was 3.08 S cm−1 from a bacterial cellulose-templated composite prepared in aqueous reaction media and afforded an approximately threefold increase in conductivity when compared with pure PPy at 1.14 S cm−1. Generally, the composites resembled wetting surfaces – with highly concentrated cuoxam solutions yielding improved hydrophilicity, while substitution of bacterial cellulose with nanocrystalline cellulose engendered a shift towards hydrophobicity. Most composites displayed a contact angle of less than 90° suggesting PPy/cellulose composites tended towards hydrophilic behavior. This study highlights investigations into the viability of cellulose solvents as a facile means to control the structure and performance of in situ functionalized cellulose nanocomposites.The in situ polymerization of polypyrrole/cellulose nanocomposites using Schweizer''s reagent is demonstrated and measured against a number of structural, electrical, and colligative properties. 相似文献